Zealand University Hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gehl, Julie
BLESS, NCT06647342: The Effect of Reduced Bleomycin in Electrochemotherapy Treatment

Not yet recruiting
4
55
Europe
Bleomycin
Julie Gehl, Roskilde University, Herlev Hospital
Cutaneous Metastasis, Cutaneous Malignant Mixed Tumor, Bleomycin Adverse Reaction, Electrochemotherapy
12/26
12/27
CAEP-B, NCT04259658: Histopathologic Effect of Calcium Electroporation on Cancer in the Skin

Completed
2
17
Europe
Calcium electroporation
Zealand University Hospital
Cancer
10/22
07/23
CaEP-R, NCT04225767: Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours

Active, not recruiting
2
19
Europe
Calcium electroporation
Zealand University Hospital, Vejle Hospital, University College Absalon, University Hospital Schleswig-Holstein
Cancer
01/23
08/23
ProTarget, NCT04341181: - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

Recruiting
2
300
Europe
Alectinib, Alecensa, Atezolizumab, Tecentriq, Avelumab, Bavencio, Axitinib, Inlyta, Erlotinib, Tarceva, Vemurafenib plus Cobimetinib (combination), Zelboraf plus Cotellic (combination), Trastuzumab plus Pertuzumab (combination), Herceptin plus Perjeta (combination), Trastuzumab emtansine, Kadcyla, Vismodegib, Erivedge, Niraparib, Zejula
Ulrik Lassen, Roche Pharma AG, Pfizer, GlaxoSmithKline
Cancer, Tumors, Neoplasms, Neoplasia
04/24
04/25
OLIGO-DK, NCT06356779: Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease

Recruiting
N/A
1200
Europe
Local ablative therapy (LAT), Metastases-directed therapy
Gitte Fredberg Persson MD PhD
Oligometastatic Disease, Metastases, Ablation Techniques, Radiotherapy, Stereotactic Radiation, Surgery
12/30
12/35
Vissing, Mille
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gehl, Julie
BLESS, NCT06647342: The Effect of Reduced Bleomycin in Electrochemotherapy Treatment

Not yet recruiting
4
55
Europe
Bleomycin
Julie Gehl, Roskilde University, Herlev Hospital
Cutaneous Metastasis, Cutaneous Malignant Mixed Tumor, Bleomycin Adverse Reaction, Electrochemotherapy
12/26
12/27
CAEP-B, NCT04259658: Histopathologic Effect of Calcium Electroporation on Cancer in the Skin

Completed
2
17
Europe
Calcium electroporation
Zealand University Hospital
Cancer
10/22
07/23
CaEP-R, NCT04225767: Calcium Electroporation as a Treatment for Cutaneous and Subcutaneous Malignant Tumours

Active, not recruiting
2
19
Europe
Calcium electroporation
Zealand University Hospital, Vejle Hospital, University College Absalon, University Hospital Schleswig-Holstein
Cancer
01/23
08/23
ProTarget, NCT04341181: - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

Recruiting
2
300
Europe
Alectinib, Alecensa, Atezolizumab, Tecentriq, Avelumab, Bavencio, Axitinib, Inlyta, Erlotinib, Tarceva, Vemurafenib plus Cobimetinib (combination), Zelboraf plus Cotellic (combination), Trastuzumab plus Pertuzumab (combination), Herceptin plus Perjeta (combination), Trastuzumab emtansine, Kadcyla, Vismodegib, Erivedge, Niraparib, Zejula
Ulrik Lassen, Roche Pharma AG, Pfizer, GlaxoSmithKline
Cancer, Tumors, Neoplasms, Neoplasia
04/24
04/25
OLIGO-DK, NCT06356779: Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease

Recruiting
N/A
1200
Europe
Local ablative therapy (LAT), Metastases-directed therapy
Gitte Fredberg Persson MD PhD
Oligometastatic Disease, Metastases, Ablation Techniques, Radiotherapy, Stereotactic Radiation, Surgery
12/30
12/35
Vissing, Mille
No trials found

Download Options